Terms: = Thyroid cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
5 results:
1. Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon.
Uekusa S; Kawashima H; Sugito K; Yoshizawa S; Shinojima Y; Igarashi J; Ghosh S; Wang X; Fujiwara K; Ikeda T; Koshinaga T; Soma M; Nagase H
Int J Oncol; 2014 May; 44(5):1669-77. PubMed ID: 24626568
[TBL] [Abstract] [Full Text] [Related]
2. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
[TBL] [Abstract] [Full Text] [Related]
3. Expression profile of the n-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma.
Viale G; Roncalli M; Grimelius L; Graziani D; Wilander E; Johansson H; Bergholm U; Coggi G
Hum Pathol; 1995 Sep; 26(9):945-50. PubMed ID: 7672794
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of n-myc immunoreactivity in medullary thyroid carcinoma.
Roncalli M; Viale G; Grimelius L; Johansson H; Wilander E; Alfano RM; Springall D; Battezzati PM; Polak JM; Coggi G
Cancer; 1994 Jul; 74(1):134-41. PubMed ID: 7911734
[TBL] [Abstract] [Full Text] [Related]
